Tuberculosis: An Overview Of Trends And Treatment. Laura

Tuberculosis has long been a disease that the human culture has been dealing with which entails significant morbidity and mortality worldwide. With dealing with such a horrific disease over the years, discoveries and evolution on the appropriate ways to contain, diagnose, and challengingly treat the disease has changed. One of the most concerning complications of this worldwide public health issue is the ability for it to quickly spread in high populated areas while becoming ever more resistant to forms of treatment not available in all locations around the world. This is a serious public

Complicating the issue of TB’s global spread, is the disease’s mutation into multi-drug resistant strains. The evolution of the bacteria is due to improper or incomplete treatment regimens. Due to TB’s ability to manifest itself in latent and active forms, there are two main sets of treatment options. Both must be strictly adhered to or the patient runs the risk of further infection and death. In terms of treating latent tuberculosis the goal is prevention and elimination. According to the Centers for Disease Control, there are four standard regimens for treating latent tuberculosis. The first is a nine-month regimen of Isoniazid taken either once daily or twice a week. The second is a shorter regiment, six months, of Isoniazid with a smaller dose, yet also taken once daily or twice a week. The third regimen lasts three months and is a combination of Isoniazid and Rifapentine taken once a week. The fourth regiment lasts four months and is completed through daily doses of Rifampin (CDC, 2012).

Now, scientists are warning signs of risks of tuberculosis and share information about bacterias and viruses. Today, when a new germ is known, they have a better chance of learning how to cure and fight it. Volunteers take the time to help in laborites in the United States, South America, Central America, and Asia. The World Health Organization reports that third of the world’s population is infected and eight million people get sick from tuberculosis that is identified to be helped by medicine from spreading the disease to

Tuberculosis is a deadly disease that is now affecting our world and the people living in it in a horrible way. Due to many factors such as poverty, HIV/AIDS, and lack of health care, many third world and developing countries have been left very vulnerable to tuberculosis. It is affecting a large part of these countries and is leading them deeper into poverty and sickness. The effort to help these countries against tuberculosis has only been slightly effective against this widespread and destructive disease.

Tuberculosis is a disease of an infectious nature caused by a bacterium known as mycobacterium tuberculosis. The disease spreads through the air. People with the disease can spread it to susceptible people through coughing, sneezing, talking or spitting. It mainly affects the lungs and other parts such as the lymph nodes and kidneys can also be affected. The symptoms for TB are fatigue, coughing, night sweats, weight loss and fever. One third of the population of the world is affected with mycobacterium tuberculosis. The rate of infection is estimated to be one person per second. About 14 million people in the world are infected with active tuberculosis. Drug resistant TB has been recorded to be a serious public health hazard in many countries. Resistant strains have developed making it difficult to treat the disease. TB has caused millions of death mainly in people living with HIV/AIDS ADDIN EN.CITE Ginsberg19981447(Ginsberg, 1998)1447144717Ginsberg, Ann M.The Tuberculosis Epidemic: Scientific Challenges and OpportunitiesPublic Health Reports (1974-)Public Health Reports (1974-)128-13611321998Association of Schools of Public Health00333549http://www.jstor.org/stable/4598234( HYPERLINK l "_ENREF_3" o "Ginsberg, 1998 #1447" Ginsberg, 1998). The World Health Organization came up with the DOTS (Directly Observed, Therapy, Short course) strategy. The approach involves diagnosing cases and treating patients with drugs for about 6-8

Tuberculosis (TB), which is brought on by contamination with an individual from the Mycobacterium tuberculosis complex, is a noteworthy reason for incapacity and passing in numerous parts of the world. The frequency (recently reported cases) of tuberculosis in Louisiana is near the normal occurrence in the United States. . In 2013, Louisiana: Ranked eleventh among the 50 states in TB rates (3 for each 100,000 people) and 22.3% of TB cases were foreign-born people (CDC, 2015). As in the U.S., frequency has diminished

TB is a major cause of mortality and morbidity globally that boils down to one small, single infection. TB can be classified into 2 stages; Latent TB and Active TB. In Latent TB, the bacteria remain in the body in an inactive or dormant state. A person will not have any symptoms because their immune mechanism has stopped the bacteria from growing. Latent TB can remain in a dormant state for year (Zager et al, 2009). However this disease can easily change to Active TB. This change mainly occurs due to the rapid increase of Mycobacterium TB within an individual when a person becomes ill or their immune system is compromise. Ninety percent of the time, those who are infected with

Among many misconceptions, tuberculosis is not a disease of the past. Tuberculosis remains a public health issue. It is estimated that one-third of the total world population is infected by tuberculosis (TB). The American lung association (2013) states, in 2011 alone there were nearly 9,000,000 new diagnosed cases of tuberculosis around the world and an estimated 1.4 million deaths because of this disease. In the United States, TB is not as common (but still a problem). In 2011, only 10,500 people reported having TB (Trends in Tuberculosis Morbidity and

Tuberculosis is a global problem that has affect the lives of many people. Though the rates very decreased immensely many third world countries still have very high rates of people infected with TB. Per the CDC: Rhode Island Health Profile, Rhode Island is 16th among the 50 states in the rates of TB (2015). Rhode Island has the 3rd high rate within the New England. Also, per the Health Department of Rhode Island, the highest rates reported in Rhode Island were in the states capital, Providence. The state of Rhode Island has a case rate of 2.8 per 100,00 people (Centers for Disease Control and Prevention [CDC], Leveling of Tuberculosis Incidences, 2016). There were 30 cases reported in RI in 2015. According to the World Bank, the incidence rate

Tuberculosis is a disease caused by Mycobacterium tuberculosis that most commonly affects the lungs. The etiologic agent can be expelled from one infected person via a sneeze or a cough, and enter the air and then the body of another person, leading to another infected person (“Tuberculosis, 2012). According to “What is TB?” (n.d.), someone who has diagnosed tuberculosis but is not receiving any form of treatment can pass the disease to up to 15 people in on year. Treatment of TB is necessary, so if symptoms are ignored, an infected person could die. Prevalence of this disease is not as common in the United States as it is in other countries. In 2014, there were approximately 9,421 reported cases; trends show that TB prevalence continues to decreases each year. Of

It is very important to know that TB can be treated and cured by taking the required medication that could last for around 6 to 9 months depending in the dosages. It is very important as recommended for all types of medication to make sure it is taking properly and is finished to avoid getting sick all over again. Selected studies were evaluated for their objective(s), design, geographical and institutional setting, and generalizability. Studies reporting health outcomes were categorized as primarily addressing efficacy or effectiveness of the intervention (Cobbelens, 2012). Tuberculosis can be cured and the social elements have always been an important issue on who will get the disease and who will be able to receive help to become cured. This disease will remain a worldwide issue for many individuals. Medication is continuing to treat as well as cure the advances of this disease and technology and medication has changed over the years, that it has become a way of shortening the amount of therapy that is needed. Perhaps in the future individuals will commit resources, plan and implement interventions that are needed to help reduce the deaths that are caused by TB. References Centers for Disease Control and Prevention. (2009). The Centers for Law The Public Health. Retrieved from HYPERLINK http//www.cdc.gov/tb/programs/TBLawPolicyHandbook.pdf http//www.cdc.gov/tb/programs/TBLawPolicyHandbook.pdf Cobbelens, F.

Tuberculosis is a disease cause by a bacterium that spreads when a person infected with the virus, sneezes, coughs, or even talks and the germs make it into the air for another person to breathe. This bacterium primarily affects the lungs and prevents the proper functioning of the respiratory system. Tuberculosis continues to be a problem in the United States and the problem is even bigger in developing countries such as India where they have seen the growth of MDR-TB cases. The following annotated bibliographies include a variety of peer review journals, a CDC website and the RX for survival video, which addresses the burden of tuberculosis in different parts of the world. The bibliographies also look at the risk factors, prevalence, mortality,

Despite the accessibility of inexpensive and successful treatment, tuberculosis still accounts for millions of cases of active disease and deaths worldwide. The disease unreasonably has an effect on the neediest persons in both high-income and developing countries. However, recent improvements in diagnostics, drugs, vaccines and enhanced implementation of present interventions have increased the outlooks for enhanced clinical care and global tuberculosis restriction.

The goal of this continuing education program is to update knowledge about prevention, assessment, diagnosis, treatment, and follow-up measures for tuberculosis and multi – resistant tuberculosis.

Although Africa and other developing nations lead in the number of those infected with tuberculosis, the infected population in the world is currently estimated to be at around one third of the